Dr. Scholl's

Last updated

Dr. Scholl's
Dr. Scholls Logo.png
Product typeFoot Care Products
OwnerScholl’s Wellness Company LLC
Country Chicago, United States
Introduced1906;117 years ago (1906)
MarketsUnited States and Canada
Previous owners
Website www.drscholls.com
1923 newspaper ad for Dr Scholl's Zino-pads for corns Dr Scholl newspaper ad 1923.png
1923 newspaper ad for Dr Scholl's Zino-pads for corns

Dr. Scholl's is a footwear and orthopedic foot care brand originating in the United States, marketed in some countries as simply "Scholl". Since 2021, global rights to the brand have been owned by investment firm Yellow Wood Partners through subsidiary Scholl's Wellness Company, having purchased the North American rights from Bayer in North America in 2019, and the international rights from Reckitt in 2021.

Contents

History

Podiatrist William Mathias Scholl started the brand in 1906. [1] He is credited with designing over 1,000 foot care products. [2] Scholl's company was named to the Fortune 500 in 1971, the same year it went public. [2] [3]

Dr. Scholl's brand

Schering-Plough bought the Dr. Scholl's brand in 1979. [3] In 2009, Merck & Co. purchased the Dr. Scholl's brand as part of its acquisition of Schering-Plough. [4] Under Merck & Co., Schering-Plough imported the product line from China [5] and had a North American distribution agreement for footwear with the Brown Shoe Company (now Caleres). Bayer bought Dr. Scholl's in 2014 as part of its acquisition of Merck & Co's consumer health unit. [6] [7] This acquisition gave them the rights to the business in North and South America. [8]

In July 2019, Bayer sold Dr. Scholl's to Yellow Wood Partners for $585 million. Yellow Wood established a new company, Scholl's Wellness Company to run the brand. [6]

Scholl brand

In 1984, Schering-Plough sold the global brand and non-North American operations to European Home Products (later SSL International), who manufactured and distributed footwear and foot care products under the Scholl brand. [9]

In 2010, Reckitt Benckiser Group purchased the Scholl brand from SSL International. [10] In 2014, Aurelius, a German private equity firm, purchased the international rights to Scholl Footwear from Reckitt Benckiser, excluding the Americas. [8] [11]

In June 2021, Reckitt sold Scholl to Yellow Wood Partners, bringing both the Scholl and Dr. Scholl's businesses together for the first time in over 40 years. [12]

Related Research Articles

The Merck Group, branded and commonly known as Merck, is a German multinational science and technology company headquartered in Darmstadt, with about 60,000 employees and a presence in 66 countries. The group includes around 250 companies; the main company is Merck KGaA in Germany. The company is divided into three business lines: Healthcare, Life Sciences and Electronics. Merck was founded in 1668 and is the world's oldest operating chemical and pharmaceutical company, as well as one of the largest pharmaceutical companies globally.

Schering-Plough Corporation was an American pharmaceutical company. It was originally the U.S. subsidiary of the German company Schering AG, which was founded in 1851 by Ernst Christian Friedrich Schering. As a result of nationalization, it became an independent company. In 1971, the Schering Corporation merged with Plough, Inc. to form Schering-Plough. On November 4, 2009 Merck & Co. merged with Schering-Plough with the new company taking the name of Merck & Co.

<span class="mw-page-title-main">SSL International</span> British company

SSL International plc was a British manufacturer of healthcare products. Its best known brands were Durex and Scholl; other significant brands were Sauber and Mister Baby. The company's name was an abbreviation of Seton Scholl London International, its predecessor businesses. The company was founded in 1929 and was listed on the London Stock Exchange. In November 2010, SSL International was folded into Reckitt Benckiser.

<span class="mw-page-title-main">Reckitt</span> British-Dutch multinational consumer goods company

Reckitt Benckiser Group plc, trading as Reckitt, is a British-Dutch multinational consumer goods company headquartered in Slough, England. It is a producer of health, hygiene and nutrition products. The company was formed in March 1999 by the merger of British company Reckitt & Colman plc and Dutch company Benckiser N.V.

<span class="mw-page-title-main">Schering AG</span>

Schering AG was a research-centered German multinational pharmaceutical company headquartered in Wedding, Berlin, which operated as an independent company from 1851 to 2006. In 2006, it was bought by Bayer AG and merged to form the Bayer subsidiary Bayer Schering Pharma AG, which was renamed Bayer HealthCare Pharmaceuticals in 2011. Schering was listed on the Frankfurt Stock Exchange and had 26,000 employees as of 2004.

Combe Incorporated, based in White Plains, New York, is an American personal-care company founded in 1949 by Ivan Combe. Combe products are sold in 64 countries on six continents. Ivan Combe primarily promoted the brand names instead of the company name. Combe owns the brands Just for Men, Sea-Bond, Vagisil, and Grecian Formula.

Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but gets a third of its revenue from the United States. Organon & Co. is an example of increasing women's representation on Wall Street with over 50% of its board of directors and executive leadership being female.

Fred Hassan, is a Pakistan-born American business executive who works for Warburg Pincus and was CEO of three global pharmaceutical companies.

Mead Johnson & Company, LLC is an American company that is a leading manufacturer of infant formula, both domestically and globally, with its flagship product Enfamil. It operates as an independent subsidiary of Reckitt.

<span class="mw-page-title-main">Air Wick</span> American brand of air freshener

Air Wick is an American brand of air freshener owned by the British multinational company Reckitt. It was first launched by creator Guy Paschal in 1943 in the United States, and is now sold worldwide.

<span class="mw-page-title-main">Coppertone (sunscreen)</span> Brand of American sunscreen

Coppertone is the brand name for an American sunscreen. Coppertone uses a variety of branding, including the Coppertone girl logo and a distinctive fragrance.

Lambertus Johannes Hermanus "Bart" Becht is a Dutch businessman. An executive with more than 35 years of business experience working with consumer brands, Becht is the former Chief Executive Officer of Reckitt, which he led from 1995 to 2011 and former Partner at JAB Holding Company, which he joined in 2012. Becht announced his retirement from JAB in 2019.

<span class="mw-page-title-main">Merck & Co.</span> American multinational pharmaceutical company

Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey, and is named for Merck Group, founded in Germany in 1668, of whom it was once the American arm. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. It is one of the largest pharmaceutical companies in the world, generally ranking in the global top five by revenue.

JAB Holding Company is a German conglomerate, headquartered in Luxembourg, that includes investments in companies operating in the areas of consumer goods, forestry, coffee, luxury fashion, animal health, and fast food, among others.

Indivior is a specialty pharmaceuticals business. It is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index. It is also listed on the NASDAQ Global Select Market.

Aurelius Group is an investment company with offices in five European countries.

<span class="mw-page-title-main">Laxman Narasimhan</span> Indian-American business executive (born 1967)

Laxman Narasimhan is an Indian-American business executive, and the chief executive officer of Starbucks.

Repatriation tax avoidance is the legal use of a tax regime within a country in order to repatriate income earned by foreign subsidiaries to a parent corporation while avoiding taxes ordinarily owed to the parent's country on the repatriation of foreign income. Prior to the passage of the Tax Cuts and Jobs Act of 2017, multinational firms based in the United States owed the U.S. government taxes on worldwide income. Companies avoided taxes on the repatriation of income earned abroad through a variety of strategies involving the use of mergers and acquisitions. Three main types of strategies emerged and were given names—the "Killer B", "Deadly D", and "Outbound F"—each of which took advantage of a different area of the Internal Revenue Code to conduct tax-exempt corporate reorganizations.

Brent Saunders is an American biopharma executive, entrepreneur, and chief executive officer and chairman of eye health company Bausch & Lomb. He is helped lead various mergers and acquisitions and overseen the mergers between Merck and Schering-Plough, the acquisition of Bausch + Lomb by Valeant Pharmaceuticals, and the $63 billion acquisition of Allergan by Abbvie. He is the founder of special-purpose acquisition company (SPAC) Vesper Healthcare Acquisition. Saunders is also executive chairman of medical aesthetics companies The Beauty Health Company and Hugel America.

References

  1. ↑ Newman, Andrew Adam (2010-03-31). "Dr. Scholl's Expands Its Insole Campaign". The New York Times. ISSN   0362-4331. Archived from the original on 2010-04-01. Retrieved 2019-08-28.
  2. 1 2 Potempa, Philip. "Dr. Scholl's has left a footprint in Northwest Indiana". Chicago Tribune. Archived from the original on 2019-10-18. Retrieved 2019-10-18.
  3. 1 2 Honan, William H. (2002-03-23). "William Scholl, 81, Designer Of a Sandal That Set a Trend". The New York Times. ISSN   0362-4331. Archived from the original on 2015-05-27. Retrieved 2019-08-28.
  4. ↑ Singer, Natasha (2009-03-09). "Merck to Buy Schering-Plough for $41 Billion". The New York Times. ISSN   0362-4331. Archived from the original on 2013-01-17. Retrieved 2019-08-28.
  5. ↑ Gardiner Harris. "As Blockbuster Claritin Goes Generic, Schering-Plough Pushes a Close Sibling" . Retrieved 22 March 2002.
  6. 1 2 Rizvic, Veneta (23 July 2019). "Bayer agrees to sells its Dr. Scholl's Business". St. Louis Business Journal. Archived from the original on 2021-04-21. Retrieved 2019-08-28.
  7. ↑ "Bayer closes acquisition of consumer care business of Merck & Co., Inc., United States, for USD 14.2 billion" (press release). Leverkusen: Bayer. 2014-10-01. Archived from the original on 2014-10-08.
  8. 1 2 "Aurelius buys Scholl shoe business from Reckitt Benckiser". Reuters. 2014-07-21. Archived from the original on 2016-03-05. Retrieved 2019-08-28.
  9. ↑ "COMPANY NEWS; Schering to Sell Foreign Assets". The New York Times. Reuters. 1987-06-27. ISSN   0362-4331. Archived from the original on 2015-05-24. Retrieved 2019-08-28.
  10. ↑ Chaudhuri, Saabira (2018-04-20). "Failed Foot-Care Gadget Trips Up Reckitt" . The Wall Street Journal. Archived from the original on 2019-08-28. Retrieved 2019-08-28.
  11. ↑ "AURELIUS Group to acquire Scholl's footwear division from Reckitt Benckiser Group plc" (Press release). Aurelius AG. 2014-07-21. Archived from the original on 2014-09-08.
  12. ↑ "Reckitt announces closing of sale of Scholl | reckitt.com". www.reckitt.com. Retrieved 2022-03-01.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.